Nkarta Inc

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
Analyst consensus
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About Nkarta Inc
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
Others were interested in
See all stocksFrequently asked questions
You need to open and fund a Saxo account to buy Nkarta Inc stock. Once the account is approved, you can login to the platform (SaxoInvestor or SaxoTrader), search for Nkarta Inc (by name) or ‘APPL’ (by ticker), choose the number of shares you wish to buy, and place your order.
The ticker symbol for Nkarta Inc is NKTX:xnas. You can use this code to find the stock in our platforms and track its price and performance.
Nkarta Inc has its primary listing on NASDAQ. You can trade Nkarta Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Nkarta Inc is available to trade on SaxoInvestor and SaxoTrader. You can buy Nkarta Inc stock directly and include it as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Nkarta Inc or others.